Last reviewed · How we verify

NCT04773496: EQUIOLD

Normative Data for Static and Dynamic Posturography (NeuroCom EQUITEST and BALANCE MASTER) in Subjects Older Than 79yrs

Completed Last updated 26 February 2021
What this trial tests

trial testing instrumental description of the subject's center of gravity (COG) sway in Equilibrium; Disorder, Labyrinth in 63 participants. Completed in 1 March 2016.

Timeline
1 March 2014
Primary endpoint
1 March 2016
1 March 2016

Quick facts

Lead sponsorIstituto Auxologico Italiano
StatusCompleted
Study typeOBSERVATIONAL
Enrollment63
Start date1 March 2014
Primary completion1 March 2016
Estimated completion1 March 2016
Sites2 locations across Italy

Drugs / interventions tested

Conditions studied

Sponsor

Istituto Auxologico Italiano — full company profile →

Who can join

80 and older, any sex, with Equilibrium; Disorder, Labyrinth or Aging. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Ageing is known to increase the risk of fall and posturographic stabilometry, both static and dynamic, are useful tools to assess postural stability. To our knowledge, no published normative data for a healthy elderly population are available.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Normative Data for the NeuroCom<sup>®</sup> Sensory Organization Test in Subjects Aged 80-89 Years.
    Perucca L, Robecchi Majnardi A, Frau S, Scarano S. · · 2021 · cited 18× · PMID 34867246 · DOI 10.3389/fnhum.2021.761262

Verify or expand the search:

Other recruiting trials for Equilibrium; Disorder, Labyrinth

Currently open trials in the same condition.

Other Istituto Auxologico Italiano trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04773496.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing